Vericel (VCEL) Cash from Financing Activities (2010 - 2026)

Vericel (VCEL) reported Cash from Financing Activities of -$3.0 million for Q1 2026, down 193.15% on a YoY basis from $3.2 million in Q1 2025, and down 379.72% sequentially from $1.1 million in Q4 2025.

Vericel (VCEL) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 17 years of Cash from Financing Activities data on file, last reported at -$3.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 193.15% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at $893000.0 (down 95.56% YoY), and the FY2025 full-year result was $7.1 million, down 62.89% from the prior year.
  • Cash from Financing Activities slipped to -$3.0 million in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.1 million in Q4 2024 to a low of -$3.0 million in Q1 2026.
  • A 5-year average of $1.6 million and a median of $1.2 million in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 1886.92% in 2024 and tumbled 193.15% in 2026, its largest moves.
  • Tracing VCEL's Cash from Financing Activities over 5 years: stood at $605000.0 in 2022, then jumped by 116.03% to $1.3 million in 2023, then jumped by 443.84% to $7.1 million in 2024, then slumped by 85.02% to $1.1 million in 2025, then plunged by 379.72% to -$3.0 million in 2026.
  • Business Quant data shows VCEL's Cash from Financing Activities at -$3.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn -2.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.98 Mn
Mar 31, 2026 -2.98 Mn
Dec 31, 2025 1.07 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 1.17 Mn
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.64 Mn
Jun 30, 2025 1.64 Mn
Mar 31, 2025 3.20 Mn
Mar 31, 2025 3.20 Mn
Dec 31, 2024 7.11 Mn
Dec 31, 2024 7.11 Mn
Sep 30, 2024 5.52 Mn
Sep 30, 2024 5.52 Mn
Jun 30, 2024 4.30 Mn
Jun 30, 2024 4.30 Mn
Mar 31, 2024 2.13 Mn
Mar 31, 2024 2.13 Mn
Dec 31, 2023 1.31 Mn
Dec 31, 2023 1.31 Mn